Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
ECM Therapeutics receives FDA 510(k) clearance for ECMT-100 WMD, validating its extracellular matrix hydrogel platform.
-
Press Release Nicox and Vester Finance Sign Shareholder Loan Agreement to Support Strategic Activities for the Company Shareholder loan agreement for up to €6.0 million over 3 yearsCompany is...
-
ROCHESTER, NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Syntec Optics (Nasdaq: OPTX), a leading provider of mission-critical technologies for vibrant end-markets - defense tech, space tech, and...
-
SHENZHEN, CHINA, June 22, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig...
-
Sanofi appoints Paulo Fontoura as Global Head of R&D Paris, June 22, 2026. Sanofi today announced the appointment of Paulo Fontoura, MD, PhD, FAAN, as Executive Vice President, Global Head of...
-
Lead program, MMT-205, licensed from MabTics Co., Ltd / Curacle Co., Ltd. is a potential best-in-class bispecific antibody which activates Tie2 and inhibits VEGF, in development for neovascular...
-
The polymeric biomaterials market size is projected to reach USD 267.25 billion by 2034 from its value of USD 69.55 billion in 2024, at a CAGR of 15.86%
-
Austin, United States, June 18, 2026 (GLOBE NEWSWIRE) -- “According to SNS Insider, The Ophthalmic Clinical Trials Market size was valued at USD 1.75 Billion in 2025 and is expected to reach USD...
-
Pharmaceutical executive brings 25+ years of international commercial leadership and rare disease experience Egham, UK – 18 June 2026 – Essential Pharma ("Essential" or "the Company"), a global...
-
Press Release Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470 Exclusive licensee for China, Ocumension, received positive pre-submission...